chr19-48398438-A-ATGC
Position:
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 1P and 4B. PM4_SupportingBS2
The ENST00000263269.4(GRIN2D):c.58_60dup(p.Leu20dup) variant causes a inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000297 in 1,112,426 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.00012 ( 0 hom., cov: 30)
Exomes 𝑓: 0.00032 ( 0 hom. )
Consequence
GRIN2D
ENST00000263269.4 inframe_insertion
ENST00000263269.4 inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.907
Genes affected
GRIN2D (HGNC:4588): (glutamate ionotropic receptor NMDA type subunit 2D) N-methyl-D-aspartate (NMDA) receptors are a class of ionotropic glutamate receptors. NMDA channel has been shown to be involved in long-term potentiation, an activity-dependent increase in the efficiency of synaptic transmission thought to underlie certain kinds of memory and learning. NMDA receptor channels are heteromers composed of the key receptor subunit NMDAR1 (GRIN1) and 1 or more of the 4 NMDAR2 subunits: NMDAR2A (GRIN2A), NMDAR2B (GRIN2B), NMDAR2C (GRIN2C), and NMDAR2D (GRIN2D). [provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -3 ACMG points.
PM4
Nonframeshift variant in NON repetitive region in ENST00000263269.4. Strenght limited to Supporting due to length of the change: 1aa.
BS2
High AC in GnomAd4 at 18 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GRIN2D | NM_000836.4 | c.58_60dup | p.Leu20dup | inframe_insertion | 3/14 | ENST00000263269.4 | NP_000827.2 | |
GRIN2D | XM_011526872.2 | c.58_60dup | p.Leu20dup | inframe_insertion | 1/12 | XP_011525174.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GRIN2D | ENST00000263269.4 | c.58_60dup | p.Leu20dup | inframe_insertion | 3/14 | 1 | NM_000836.4 | ENSP00000263269 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000121 AC: 18AN: 148842Hom.: 0 Cov.: 30
GnomAD3 genomes
AF:
AC:
18
AN:
148842
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000324 AC: 312AN: 963584Hom.: 0 Cov.: 28 AF XY: 0.000326 AC XY: 148AN XY: 454632
GnomAD4 exome
AF:
AC:
312
AN:
963584
Hom.:
Cov.:
28
AF XY:
AC XY:
148
AN XY:
454632
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000121 AC: 18AN: 148842Hom.: 0 Cov.: 30 AF XY: 0.0000965 AC XY: 7AN XY: 72564
GnomAD4 genome
AF:
AC:
18
AN:
148842
Hom.:
Cov.:
30
AF XY:
AC XY:
7
AN XY:
72564
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 19, 2024 | This variant, c.58_60dup, results in the insertion of 1 amino acid(s) of the GRIN2D protein (p.Leu20dup), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (no rsID available, gnomAD 0.007%). This variant has not been reported in the literature in individuals affected with GRIN2D-related conditions. ClinVar contains an entry for this variant (Variation ID: 1481276). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Developmental and epileptic encephalopathy, 46 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Oct 11, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at